The acquisition of OTTR Complete Transplant Management will enable CareDx to integrate the EMRs of patients at transplant centers with longitudinal patient surveillance data.
While large health systems develop comprehensive precision medicine strategies, smaller hospitals don't want to wait for pharmacogenomics technology.
Major EHR vendor Cerner would like to see the SMART on FHIR protocol take off as it seeks to make genomic data just another element of a patient's record.
Research presented at AMIA this month demonstrated a computing method for predicting family pedigrees by mining demographic data in electronic health records.
In a poster presented at AMIA, just one-third of IGNITE participants had external structured genomic test results in their EHRs to inform clinical decision support.
Led by researchers at BBMRI-ERIC, the effort intends to clarify how entities should share data, including genomics information, across institutions and countries.
The EHR giant says it's responding to customer demand for integrating genomic data into patient records and workflows without overwhelming front-line clinicians.
Starting in early 2019, Yale plans to sign up at least 100,000 patients to analyze their genomes and EHR data for research and return of clinically actionable results.
The framework, called HEAL, could be used as an early screening test for AAA and as a personal health management tool. In addition, it may be applicable to other complex diseases.
The system relies on the use of scannable safety code cards containing patient data, along with a web portal and automated analysis tools that deliver customized diagnostic reports.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.